Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

Abstract #118541

Elaine F. Cassidy, PhD, Research and Evaluation, Robert Wood Johnson Foundation, Route 1 North and College Road East, Princeton, NJ 08543, 609.627.7611, ecassid@rwjf.org, Kristin B. Schubert, MPH, Addiction Prevention and Treatment Team, Robert Wood Johnson Foundation, Route 1 North and College Road East, Princeton, NJ 08543, Traci Rieckmann, PhD, Department of Public Health and Preventive Medicine, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97201-3098, Jamie F. Chriqui, PhD, MHS, Center for Health Policy and Legislative Analysis, The MayaTech Corporation, 1100 Wayne Avenue, Suite 900, Silver Spring, MD 20910-3921, and J. Aaron Johnson, PhD, Institute for Behavioral Research, University of Georgia - Athens, 100 Barrow Hall, Athens, GA 30602.

Recently, the need to increase the use of evidence-based decision-making in the treatment for alcohol and drug addiction has received a great deal of attention. The first step in the process of dissemination and implementation of evidence-based practice involves the development of consensus of what, in fact, are “evidence-based” practices. Factors at the agency, state and federal levels need to support the adoption and increased use of research-based practices in substance use dependence treatment. The first paper summarizes conclusions made during a national meeting of representatives from providers, funding agencies, and treatment research organizations, during which consensus was gained on evidence-based practices at the treatment agency-level and on the agency-level characteristics that need to be in place in order for such practices to be used. The second paper highlights what states need in order to promote the increased use of evidence-based practices among their own treatment providers. The third paper provides data on which evidence-based practices agencies provide. This panel also includes a fourth paper that describes the challenges states face in trying to improve their treatment practices against a backdrop of restricted and limited budgetary support. This paper highlights what Oregon is doing to increase the use of evidence-based treatment practices in that state. Finally, the fifth paper provides a cross-state analysis that describes how different states are making changes to their licensing and accreditation practices in efforts to increase the use of evidence-based practices in substance use dependence treatment.

Learning Objectives:

• See individual abstracts.

Presenting author's disclosure statement:

I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.